Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus ; volume:13 ; number:1 ; day:10 ; month:8 ; year:2022 ; pages:1-18 ; date:12.2022
Nature Communications ; 13, Heft 1 (10.8.2022), 1-18, 12.2022
- Creator
-
Koch, Jana
Schober, Sebastian J.
Hindupur, Sruthi V.
Schöning, Caroline
Klein, Florian G.
Mantwill, Klaus
Ehrenfeld, Maximilian
Schillinger, Ulrike
Hohnecker, Timmy
Qi, Pan
Steiger, Katja
Aichler, Michaela
Gschwend, Jürgen E.
Nawroth, Roman
Holm, Per Sonne
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-022-32087-5
- URN
-
urn:nbn:de:101:1-2022102603173818517323
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Koch, Jana
- Schober, Sebastian J.
- Hindupur, Sruthi V.
- Schöning, Caroline
- Klein, Florian G.
- Mantwill, Klaus
- Ehrenfeld, Maximilian
- Schillinger, Ulrike
- Hohnecker, Timmy
- Qi, Pan
- Steiger, Katja
- Aichler, Michaela
- Gschwend, Jürgen E.
- Nawroth, Roman
- Holm, Per Sonne
- SpringerLink (Online service)
Other Objects (12)
Viral Oncolytic Therapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic virotherapy of glioblastoma
Oncolytic viruses for cancer immunotherapy
The oncolytic adenovirus XVir-N-31 and CDK4/6 inhibitors: Elucidating the mechanisms driving the therapeutic synergy
Perspectives on immunotherapy via oncolytic viruses
Oncolytic viruses as therapeutic cancer vaccines
Two roads for oncolytic immunotherapy development
Oncolytic activities of host defense peptides
Oncolytic herpes simplex virus and immunotherapy
Immune checkpoint modulation enhances oncolytic virotherapy
Modulation of dendritic cell biology by oncolytic adenoviruses and by melanoma cells lysed by oncolytic adenoviruses
Viral Oncolytic Therapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic virotherapy of glioblastoma
Oncolytic viruses for cancer immunotherapy
The oncolytic adenovirus XVir-N-31 and CDK4/6 inhibitors: Elucidating the mechanisms driving the therapeutic synergy
Perspectives on immunotherapy via oncolytic viruses
Oncolytic viruses as therapeutic cancer vaccines
Two roads for oncolytic immunotherapy development
Oncolytic activities of host defense peptides
Oncolytic herpes simplex virus and immunotherapy
Immune checkpoint modulation enhances oncolytic virotherapy
Modulation of dendritic cell biology by oncolytic adenoviruses and by melanoma cells lysed by oncolytic adenoviruses
Viral Oncolytic Therapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic virotherapy of glioblastoma
Oncolytic viruses for cancer immunotherapy
The oncolytic adenovirus XVir-N-31 and CDK4/6 inhibitors: Elucidating the mechanisms driving the therapeutic synergy
Perspectives on immunotherapy via oncolytic viruses
Oncolytic viruses as therapeutic cancer vaccines
Two roads for oncolytic immunotherapy development
Oncolytic activities of host defense peptides
Oncolytic herpes simplex virus and immunotherapy
Immune checkpoint modulation enhances oncolytic virotherapy